Coloplast A/S Price To Earning vs. Net Income
| CLPBF Stock | USD 121.15 0.15 0.12% |
For Coloplast A/S profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coloplast A/S to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coloplast AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coloplast A/S's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coloplast AS over time as well as its relative position and ranking within its peers.
Coloplast |
Coloplast A/S Net Income vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Coloplast A/S's current stock value. Our valuation model uses many indicators to compare Coloplast A/S value to that of its competitors to determine the firm's financial worth. Coloplast AS is rated below average in price to earning category among its peers. It is rated fifth in net income category among its peers making up about 125,593,808 of Net Income per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Coloplast A/S's earnings, one of the primary drivers of an investment's value.Coloplast Net Income vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Coloplast A/S |
| = | 37.47 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Coloplast A/S |
| = | 4.71 B |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Coloplast Net Income Comparison
Coloplast is currently under evaluation in net income category among its peers.
Coloplast A/S Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Coloplast A/S, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Coloplast A/S will eventually generate negative long term returns. The profitability progress is the general direction of Coloplast A/S's change in net profit over the period of time. It can combine multiple indicators of Coloplast A/S, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.
Coloplast Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Coloplast A/S. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Coloplast A/S position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Coloplast A/S's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Coloplast A/S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Use Investing Themes to Complement your Coloplast A/S position
In addition to having Coloplast A/S in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hybrid Mix Funds Thematic Idea Now
Hybrid Mix Funds
Funds or Etfs that are made of portfolios of stocks, bonds, or cash instruments with different maturity horizons and characteristics. The Hybrid Mix Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hybrid Mix Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Coloplast Pink Sheet
To fully project Coloplast A/S's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Coloplast A/S at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Coloplast A/S's income statement, its balance sheet, and the statement of cash flows.